References
- Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure (Review). J Am Coll Cardiol 2004;43:1439–44.
- El-Mesallamy HO, Abdel Hamid SG, Gad MZ. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake. Kidney Blood Press Res 2008;31:189–95.
- Coen G, Mantella D, Sardella D, Beraldi MP, Ferrari I, Pierantozzi A, Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients. J Nephrol 2009;22:616–22.
- Lu Q, Cheng LT, Wang T, Wan J, Liao LL, Zeng J, Visceral fat, arterial stiffness, and endothelial function in peritoneal dialysis patients. J Ren Nutr 2008;18:495–502.
- Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue – a novel endocrine organ of interest to the nephrologist (Review). Nephrol Dial Transplant 2002;17:191–5.
- Axelsson J, Heimburger O, Stanvinkel P. Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol 2006;151:165–74.
- Stenvinkel P, Pecoits-Filho R, Lindholm B. Leptin, ghrelin, and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease? Adv Ren Replace Ther 2003;10:332–45.
- Stenvinkel P, Lindholm B, Lönnqvist F, Katzarski K, Heimbürger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;11:1303–9.
- Steiber A, Leon JB, Secker D, McCarthy M, McCann L, Serra M, Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population. J Ren Nutr 2007;17:336–42.
- World Health Organization. Obesity: preventing and managing the global epidemic. Report of a World Health Organization Consultation. WHO Obesity Technical Report Series, No. 894. Geneva: WHO; 2000.
- Odetti P, Garibaldi S, Gurreri G, Aragno I, Dapino D, Pronzato MA, Marinari UM. Protein oxidation in hemodialysis and kidney transplantation. Metabolism 1996;45:1319–22.
- Guebe-Egziabher F, Bernhard J, Geelen G, Malvoisin E, Hadj-Aissa A, Fouque D. Leptin, adiponectin and ghrelin dysregulation in chronic kidney disease. J Ren Nutr 2005;15:116–20.
- Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003;52:942–7.
- Scholze A, Tepel M. Role of leptin in reverse epidemiology in chronic kidney disease. Semin Dial 2007;20:534–8.
- Lam MF, Leung JC, Lo WK, Tam S, Chong MC, Lui SL, Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis. Nephrol Dial Transplant 2007;22:1445–50.
- Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 2005;115:1659–65.
- Park JH, Gil HW, Yang JO, Lee EY, Hong SY. Total and high molecular weight adiponectin concentrations in plasma of patients with end-stage renal disease before and after peritoneal dialysis. Nephrology (Carlton) 2008;13:181–5.
- Chen HY, Kao TW, Huang JW, Chu TS, Wu KD. Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients. Blood Purif 2008;26:138–44.
- Teta D, Maillard M, Halabi G, Burnier M. The leptin/adiponectin ratio: potential implications for peritoneal dialysis. Kidney Int Suppl 2008;S112–8. Review.
- Chung SH, Lindholm B, Lee HB. Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival. Perit Dial Int 2000;20:19–26.
- Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 2003;64:1838–44.
- Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004;66:866.
- Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 2000;20:715–21.